14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
May 02, 2024 Sell 893 Pease Flavia Common Stock
Mar 08, 2024 Sell 808 Knell Michael Gunnar Common Stock
Mar 04, 2024 Sell 1 750 Knell Michael Gunnar Common Stock
Mar 04, 2024 Sell 1 000 Knell Michael Gunnar Common Stock
Mar 01, 2024 Sell 412 Parisotto Shannon M Common Stock
Feb 29, 2024 Sell 100 Parisotto Shannon M Common Stock
Feb 29, 2024 Sell 3 686 Parisotto Shannon M Common Stock
Feb 29, 2024 Sell 5 000 Creamer Victoria L Common Stock
Feb 22, 2024 Sell 4 050 Barbo William D Common Stock
Feb 16, 2024 Sell 4 000 Foster James C Common Stock
Feb 15, 2024 Buy 5 882 Parisotto Shannon M Common Stock
Feb 15, 2024 Sell 291 Parisotto Shannon M Common Stock
Feb 15, 2024 Sell 1 290 Parisotto Shannon M Common Stock
Feb 15, 2024 Sell 1 617 Parisotto Shannon M Common Stock
Feb 15, 2024 Sell 610 Parisotto Shannon M Common Stock
Feb 15, 2024 Sell 632 Parisotto Shannon M Common Stock
Feb 15, 2024 Sell 604 Parisotto Shannon M Common Stock
Feb 15, 2024 Sell 749 Parisotto Shannon M Common Stock
Feb 15, 2024 Sell 89 Parisotto Shannon M Common Stock
Feb 15, 2024 Sell 5 882 Parisotto Shannon M Stock Options (Right to Buy)
Feb 15, 2024 Sell 838 Laplume Joseph W Common Stock
Feb 15, 2024 Sell 424 Girshick Birgit Common Stock
Feb 01, 2024 Buy 399 Kemps-polanco Reshema Stock Options (Right to Buy)
Feb 01, 2024 Buy 170 Kemps-polanco Reshema Common Stock
Jan 29, 2024 Buy 2 934 Creamer Victoria L Common Stock
Jan 29, 2024 Sell 924 Creamer Victoria L Common Stock
Jan 29, 2024 Buy 23 741 Foster James C Common Stock
Jan 29, 2024 Sell 10 540 Foster James C Common Stock
Jan 29, 2024 Buy 2 070 Parisotto Shannon M Common Stock
Jan 29, 2024 Sell 535 Parisotto Shannon M Common Stock
Jan 29, 2024 Buy 2 934 Barbo William D Common Stock
Jan 29, 2024 Sell 744 Barbo William D Common Stock
Jan 29, 2024 Buy 3 279 Laplume Joseph W Common Stock
Jan 29, 2024 Sell 994 Laplume Joseph W Common Stock
Jan 29, 2024 Buy 3 451 Girshick Birgit Common Stock
Jan 29, 2024 Sell 1 135 Girshick Birgit Common Stock
Jan 29, 2024 Buy 948 Knell Michael Gunnar Common Stock
Jan 29, 2024 Sell 313 Knell Michael Gunnar Common Stock
Jan 29, 2024 Buy 2 115 Parisotto Shannon M Common Stock
Jan 29, 2024 Sell 555 Parisotto Shannon M Common Stock
Jan 29, 2024 Buy 3 526 Girshick Birgit Common Stock
Jan 29, 2024 Sell 1 159 Girshick Birgit Common Stock
Jan 29, 2024 Buy 968 Knell Michael Gunnar Common Stock
Jan 29, 2024 Sell 326 Knell Michael Gunnar Common Stock
Jan 29, 2024 Buy 3 350 Laplume Joseph W Common Stock
Jan 29, 2024 Sell 1 025 Laplume Joseph W Common Stock
Jan 29, 2024 Buy 2 997 Creamer Victoria L Common Stock
Jan 29, 2024 Sell 953 Creamer Victoria L Common Stock
Jan 29, 2024 Buy 2 997 Barbo William D Common Stock
Jan 29, 2024 Sell 770 Barbo William D Common Stock
Jan 29, 2024 Buy 24 253 Foster James C Common Stock
Jan 29, 2024 Sell 10 757 Foster James C Common Stock
Jan 29, 2024 Buy 17 436 Foster James C Common Stock
Jan 29, 2024 Sell 12 710 Foster James C Common Stock
Jan 29, 2024 Sell 17 436 Foster James C Stock Options (Right to Buy)
Jan 22, 2024 Buy 0 Kemps-polanco Reshema Common Stock
Jan 10, 2024 Buy 5 916 Girshick Birgit Common Stock
Jan 10, 2024 Sell 4 617 Girshick Birgit Common Stock
Jan 10, 2024 Buy 5 916 Girshick Birgit Common Stock
Jan 10, 2024 Sell 4 590 Girshick Birgit Common Stock
Jan 10, 2024 Sell 5 916 Girshick Birgit Stock Options (Right to Buy)
Dec 14, 2023 Buy 2 145 Creamer Victoria L Common Stock
Dec 14, 2023 Buy 3 381 Creamer Victoria L Common Stock
Dec 14, 2023 Sell 5 526 Creamer Victoria L Common Stock
Dec 14, 2023 Sell 3 381 Creamer Victoria L Stock Options (Right to Buy)
Dec 14, 2023 Sell 2 145 Creamer Victoria L Stock Options (Right to Buy)
Nov 30, 2023 Sell 1 850 Laplume Joseph W Common Stock
Nov 20, 2023 Buy 1 322 Girshick Birgit Common Stock
Nov 14, 2023 Buy 5 620 Foster James C Common Stock
Nov 09, 2023 Buy 9 128 Laplume Joseph W Common Stock
Nov 09, 2023 Sell 2 585 Laplume Joseph W Common Stock
Nov 09, 2023 Sell 6 543 Laplume Joseph W Common Stock
Nov 09, 2023 Sell 9 128 Laplume Joseph W Stock Options (Right to Buy)
Aug 24, 2023 Buy 1 000 Wallman Richard F Common Stock
Aug 10, 2023 Buy 5 511 Barbo William D Common Stock
Aug 10, 2023 Sell 5 763 Barbo William D Common Stock
Aug 10, 2023 Sell 5 511 Barbo William D Stock Options (Right to Buy)
Aug 10, 2023 Buy 1 471 Knell Michael Gunnar Common Stock
Aug 10, 2023 Sell 1 471 Knell Michael Gunnar Common Stock
Aug 10, 2023 Sell 1 471 Knell Michael Gunnar Stock Options (Right to Buy)
Aug 10, 2023 Sell 2 500 Foster James C Common Stock
Aug 10, 2023 Sell 700 Laplume Joseph W Common Stock
Jul 03, 2023 Buy 95 Mackay Martin Common Stock
Jun 01, 2023 Buy 1 528 Knell Michael Gunnar Common Stock
May 31, 2023 Buy 338 Mackay Martin Common Stock
May 29, 2023 Sell 223 Laplume Joseph W Common Stock
May 29, 2023 Sell 36 Knell Michael Gunnar Common Stock
May 29, 2023 Sell 1 274 Foster James C Common Stock
May 28, 2023 Sell 125 Laplume Joseph W Common Stock
May 28, 2023 Sell 24 Knell Michael Gunnar Common Stock
May 27, 2023 Sell 184 Laplume Joseph W Common Stock
May 27, 2023 Sell 36 Knell Michael Gunnar Common Stock
May 27, 2023 Sell 137 Pease Flavia Common Stock
May 26, 2023 Buy 2 189 Laplume Joseph W Common Stock
May 26, 2023 Buy 5 252 Laplume Joseph W Stock Options (Right to Buy)
May 26, 2023 Buy 670 Knell Michael Gunnar Common Stock
May 26, 2023 Buy 1 607 Knell Michael Gunnar Stock Options (Right to Buy)
May 26, 2023 Buy 2 215 Pease Flavia Common Stock
May 26, 2023 Buy 5 314 Pease Flavia Stock Options (Right to Buy)
Mar 01, 2021 Sell 350 Girshick Birgit Common Stock
INSIDER POWER
-0.482
Last 100 transactions
Buy: 164 068 | Sell: 161 687 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be negative at a ratio of -0.482.

In total, the insiders bought 164 068 and sold 161 687 CRL shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Charles River Laboratories International Inc

Charles River Laboratories International Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent r... CRL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT